DAILYZ HEALTH NEWS

August 4, 2026 Evan Vega

FDA expands Pluvicto approval to earlier-stage metastatic prostate cancer, nearly doubling eligible patients

The FDA approved Pluvicto with androgen receptor inhibitors for earlier-stage PSMA-positive metastatic hormone-sensitive prostate cancer, expanding patient eligibility.

Health

August 4, 2026 Evan Vega

Prescription blood thinner recalled nationwide amid FDA warning

Alkem Laboratories and Major Pharmaceuticals recalled 299,520 dabigatran etexilate capsules nationwide due to FDA quality concerns.

Health

August 4, 2026 Evan Vega

Chipotle pulls jalapeños from some restaurants amid salmonella probe sickening over 100

Chipotle removed jalapeños from some Minnesota restaurants after a Salmonella Javiana outbreak sickened 110 people linked to the peppers.

Health

July 24, 2026 Evan Vega

CDC Investigates 7,400 Cyclospora Cases as Second Outbreak Cluster Emerges

The CDC is investigating over 7,400 suspected Cyclospora cases and a second outbreak cluster amid a record U.S. cyclosporiasis surge in 2026.

Health

July 23, 2026 Evan Vega

Nearly 1.6 million cartons of eggs recalled over salmonella risk in multi-state outbreak

Midwest Poultry Services recalled nearly 1.6 million dozen eggs from Texas farms due to potential Salmonella Enteritidis contamination risk.

Health

July 23, 2026 Evan Vega

US quarantines citizens at New York military base after return from Congo amid Ebola concerns

Fourteen Americans returning from Congo were quarantined for four days at a New York military base due to Ebola outbreak precautions.

Health

July 21, 2026 Evan Vega

ViiV Healthcare to present phase IIIb data comparing Dovato against Biktarvy in HIV treatment-naïve adults at AIDS 2026

ViiV Healthcare presented Phase IIIb VOGUE trial data comparing two-drug Dovato to three-drug Biktarvy in treatment-naïve adults with HIV at AIDS 2026.

Health

July 15, 2026 Evan Vega

CDC investigates multistate cyclosporiasis outbreak with nearly 7,000 suspected cases

The CDC is investigating nearly 7,000 suspected cyclosporiasis cases across 34 states since May 2026, with 1,645 confirmed infections.

Health

July 15, 2026 Evan Vega

FDA approves Leqembi Iqlik subcutaneous injection as starting dose for early Alzheimer’s disease

The FDA approved Leqembi Iqlik subcutaneous injections as a once-weekly starting dose for early Alzheimer’s disease treatment at home.

Health

July 14, 2026 Evan Vega

Cyclosporiasis Cases Surpass 3,000 as Michigan Identifies Lettuce and Salad Greens as Potential Source

Michigan reports over 3,000 cyclosporiasis cases linked to lettuce and salad greens in southeast counties as of July 13, 2026.

DAILYZ HEALTH NEWS

DAILYZ HEALTH NEWS

FDA Approves Roivant’s Lisraya (brepocitinib) as First Oral Drug for Dermatomyositis

FDA Recalls 12 Herbal Supplements Over Hidden Drug Ingredients

Pennsylvania records its first measles deaths in 35 years

FDA approves brepocitinib, the first oral drug for dermatomyositis in adults

FDA Elevates Massive Egg Recall to Highest-Risk Salmonella Warning

FDA Approves Roivant’s Lisraya (brepocitinib) as First Oral Drug for Dermatomyositis

FDA Recalls 12 Herbal Supplements Over Hidden Drug Ingredients

Pennsylvania records its first measles deaths in 35 years

FDA approves brepocitinib, the first oral drug for dermatomyositis in adults

FDA Approves Roivant’s Lisraya (brepocitinib) as First Oral Drug for Dermatomyositis

FDA Recalls 12 Herbal Supplements Over Hidden Drug Ingredients

Pennsylvania records its first measles deaths in 35 years

FDA approves brepocitinib, the first oral drug for dermatomyositis in adults

FDA Elevates Massive Egg Recall to Highest-Risk Salmonella Warning

FDA Approves Roivant’s Lisraya (brepocitinib) as First Oral Drug for Dermatomyositis

FDA Recalls 12 Herbal Supplements Over Hidden Drug Ingredients

Pennsylvania records its first measles deaths in 35 years

FDA approves brepocitinib, the first oral drug for dermatomyositis in adults

FDA Approves Roivant’s Lisraya (brepocitinib) as First Oral Drug for Dermatomyositis

FDA Recalls 12 Herbal Supplements Over Hidden Drug Ingredients

Pennsylvania records its first measles deaths in 35 years

FDA approves brepocitinib, the first oral drug for dermatomyositis in adults

FDA Elevates Massive Egg Recall to Highest-Risk Salmonella Warning

FDA expands Pluvicto approval to earlier-stage metastatic prostate cancer, nearly doubling eligible patients

Prescription blood thinner recalled nationwide amid FDA warning

Chipotle pulls jalapeños from some restaurants amid salmonella probe sickening over 100

CDC Investigates 7,400 Cyclospora Cases as Second Outbreak Cluster Emerges

Nearly 1.6 million cartons of eggs recalled over salmonella risk in multi-state outbreak

US quarantines citizens at New York military base after return from Congo amid Ebola concerns

ViiV Healthcare to present phase IIIb data comparing Dovato against Biktarvy in HIV treatment-naïve adults at AIDS 2026

CDC investigates multistate cyclosporiasis outbreak with nearly 7,000 suspected cases

FDA approves Leqembi Iqlik subcutaneous injection as starting dose for early Alzheimer’s disease

Cyclosporiasis Cases Surpass 3,000 as Michigan Identifies Lettuce and Salad Greens as Potential Source